Secondary sale of shares in Doktor.se (SE) — SEK 100 million Healthcare Secondary sale of shares in Doktor.se (SE) — SEK 100 million
Rights issue in Fingerprint Cards AB (SE) — SEK 160 million TMT Rights issue in Fingerprint Cards AB (SE) — SEK 160 million
Directed share issue in Faron Pharmaceuticals Ltd (FI) — EUR 12 million Healthcare Directed share issue in Faron Pharmaceuticals Ltd (FI) — EUR 12 million
Rights issue in BibbInstruments AB (SE) — SEK 28 million Healthcare Rights issue in BibbInstruments AB (SE) — SEK 28 million
Rights issue and a directed issue in SciBase Holding AB (SE) — SEK 53.4 million Healthcare Rights issue and a directed issue in SciBase Holding AB (SE) — SEK 53.4 million
Senior secured bonds by ABAX Group AS (NO) – SEK 900 million TMT Senior secured bonds by ABAX Group AS (NO) – SEK 900 million
Rights issue in Nimbus Group AB (SE) — SEK 356 million Consumer & Retail Rights issue in Nimbus Group AB (SE) — SEK 356 million
Sale of SpinChip Diagnostics ASA (NO) to bioMérieux SA (FR) — NOK 1,624 million. Healthcare Sale of SpinChip Diagnostics ASA (NO) to bioMérieux SA (FR) — NOK 1,624 million.
Sale of Otime Subsea (NO) to Halliburton Company (US) – Amount not disclosed Oil Services Sale of Otime Subsea (NO) to Halliburton Company (US) – Amount not disclosed
Sale of a majority stake in Aider AS (NO) to Castik Capital (LXM) – Amount not disclosed Business Services Sale of a majority stake in Aider AS (NO) to Castik Capital (LXM) – Amount not disclosed
Equity raise in Oda Group Holding AB (SE) – SEK 1,265 million Consumer & Retail Equity raise in Oda Group Holding AB (SE) – SEK 1,265 million
Private placement in Lytix Biopharma AS (NO) — NOK 100 million Healthcare Private placement in Lytix Biopharma AS (NO) — NOK 100 million